Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
16.7%
% of FBT's 31 holdings also in IDNA
10.9%
% of IDNA's 51 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 3.4% | 5.2% | 3.4% |
|
INCYTE CORP | 3.4% | 4.0% | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% | 4.2% | 3.4% |
|
REGENERON PHARMACEUTICALS | 3.4% | 3.7% | 3.4% |
|
MODERNA, INC. | 3.1% | 2.9% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IDNA
|
NEUROCRINE BIOSCIENCES INC | 3.7% |
 |
GENMAB A/S SPONSORED ADR | 3.5% |
|
REPLIGEN CORP | 3.5% |
|
SAREPTA THERAPEUTICS INC | 3.5% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% |
|
BIOGEN IDEC INC | 3.4% |
 |
ARGENX SE ADR | 3.4% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.4% |
|
ACADIA PHARMACEUTICALS INC | 3.4% |
FBT Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.8% |
 |
ROCHE HOLDING LTD | -5.5% |
 |
SANOFI-AVENTIS | -5.5% |
 |
GSK PLC | -5.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -5.2% |
|
ASTRAZENECA PLC | -5.1% |
|
GENMAB A/S | -4.6% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.3% |
|
REVOLUTION MEDICINES, INC. | -4.0% |
|
MERCK & CO. INC. | -3.9% |